Table 1.
Demographic Characteristics of Included SBI Patients with (Group 3) and without (Group 1) Previously Reported Health Issues
| Variable | SBI Patients Group 1 (n = 79) | SBI Patients Group 3 (n = 81) | P (2-sided) |
|---|---|---|---|
| Age, mean in years ± SD | 57.77 ± 10.18 | 53.89 ± 9.36 | 0.015* |
| Reason of breast implantation, n (%) | |||
| Cosmetic | 52 (65.8) | 62 (76.6) | 0.134 |
| Reconstruction after breast cancer | 25 (31.6) | 15 (18.5) | |
| BRCA mutation | 12 (15.2) | 4 (4.9) | |
| Other | 2 (2.6) | 4 (4.9) | |
| Reintervention, n (%) | |||
| Yes | 53 (67.1) | 69 (85.2) | 0.007* |
| No | 26 (32.9) | 12 (14.8) | |
| Rupture rate of breast implant(s), n (%) | |||
| Yes | 21 (26.6) | 24 (29.6) | 0.668 |
| No | 58 (73.4) | 57 (70.4) | |
| Duration of silicone exposure, mean in years ± SD | 16.2 ± 10.2 | 15.4 ± 7.2 | 0.004* |
| Clinical score,† mean ± SD | 2.4 ± 1.7 | 4.1 ± 1.4 | 0.008* |
*Statistical significant results (P < 0.05).
†Clinical score: amount of other symptoms (range 0–6).